Patent US4347368A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4347368A Expired / Lapsed US ⏱️ 0.0 years remaining

3-Substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

Assignee: Merck and Co Inc
•
Filing: 1980-11-14
•
Granted: 1982-08-31
•
Expires: 2000-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 3- and 6-substituted 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acids having the structure: ##STR1## wherein R 6 , R 7 and R 8 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and aralkyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David B. R. Johnston
  • 👤 Susan M. Schmitt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 16:40
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/26; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D477/10; C07D477/12; C07D477/16; C07D477/20; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/10

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 173 words
A compound selected from the group consisting of: ##STR101## wherein R 5 is a removable protecting group or a pharmaceutically acceptable ester moiety; and R 6 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, substituted and unsubstituted: alkyl, alkenyl, and alkynyl, having from 1-10 carbon atoms; cycloalkyl, cycloalkylalkyl, and alkylcycloalkyl, having 3-6 carbon atoms in the cycloalkyl ring and 1-6 carbon atoms in the alkyl moieties; phenyl, aralkyl, aralkenyl, and aralkynyl wherein the aryl moiety is phenyl and the linear chain has 1-6 carbon atoms; wherein the substituent or substituents relative to the above-named radicals are selected from the group consisting of: amino, mono-, di- and trialkylamino, hydroxyl, alkoxyl, mercapto, alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxy; and wherein the alkyl moieties of the above-recited substituents have 1-6 carbon atoms; when R 7 /R 6 is hydrogen, R 6 /R 7 is not 1-hydroxyethyl when --SR 8 is --SCH 2 CH 2 NH 2 ; X is chloro or bromo.
Claim 2
Dependent Claim 173 words
A compound selected from the group consisting of: ##STR101## wherein R 5 is a removable protecting group or a pharmaceutically acceptable ester moiety; and R 6 , R 7 , and R 8 are independently selected from the group consisting of hydrogen, substituted and unsubstituted: alkyl, alkenyl, and alkynyl, having from 1-10 carbon atoms; cycloalkyl, cycloalkylalkyl, and alkylcycloalkyl, having 3-6 carbon atoms in the cycloalkyl ring and 1-6 carbon atoms in the alkyl moieties; phenyl, aralkyl, aralkenyl, and aralkynyl wherein the aryl moiety is phenyl and the linear chain has 1-6 carbon atoms; wherein the substituent or substituents relative to the above-named radicals are selected from the group consisting of: amino, mono-, di- and trialkylamino, hydroxyl, alkoxyl, mercapto, alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxy; and wherein the alkyl moieties of the above-recited substituents have 1-6 carbon atoms; when R 7 /R 6 is hydrogen, R 6 /R 7 is not 1-hydroxyethyl when --SR 8 is --SCH 2 CH 2 NH 2 ; X is chloro or bromo.
Claim 3
Dependent Claim 62 words
A compound having the structure: ##STR102## wherein R 5 is a removable protecting group or a pharmaceutically acceptable ester moiety R 6 is hydrogen or methyl and R 8 is selected from the group consisting of: ##STR103## when R 7 /R 6 is hydrogen, R 6 /R 7 is not 1-hydroxyethyl when --SR 8 is --SCH 2 CH 2 NH 2 .
Claim 4
Dependent Claim 62 words
A compound having the structure: ##STR102## wherein R 5 is a removable protecting group or a pharmaceutically acceptable ester moiety R 6 is hydrogen or methyl and R 8 is selected from the group consisting of: ##STR103## when R 7 /R 6 is hydrogen, R 6 /R 7 is not 1-hydroxyethyl when --SR 8 is --SCH 2 CH 2 NH 2 .

References Cited (Backward Citations)

US4234596A Cited
US4232036A Cited
US4281002A Cited
US4264621A Cited
US4269873A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-08-30 1986-03-01 1986-08-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-08-30 1990-03-01 1990-08-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-08-30 1994-03-01 1994-08-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag